Exelixis, Inc. (EXEL) vs Insmed, Inc. (INSM)

• Exelixis, Inc. EXEL 62.11 ▼ −1.15%
• Insmed, Inc. INSM 96.27 ▼ −2.96%

Exelixis, Inc. and Insmed, Inc. are both Biotechnology companies. Insmed, Inc. is the larger, with a market value of $21.7B against $15.6B — 1.4× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; Exelixis, Inc. trades at 18.8×. Insmed, Inc. grew revenue faster over the last twelve months: 185.8% against 9.23%. Exelixis, Inc. has the higher net margin (35.3% vs −76.9%) and the higher return on invested capital (60.5% vs −329.2%). Across the 19 metrics below, Exelixis, Inc. leads on 16 and Insmed, Inc. on 3.